
|Articles|December 8, 2021
Supplements and Featured Publications
- Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone
- Volume 27
- Issue 20
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
Advertisement
Supplementary Appendix
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
2
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
3
Disparities Drive Shifting Pancreatic Cancer Survival Trends
4
Postpandemic Nursing Home Capacity Declines Tied to Longer Hospital Stays, Increased Patient Travel
5





























































